Delivery Order SPE2DB22D2206-SPE2DB24FJF72

Award Date 7/16/24
Potential Completion Date 8/6/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a Delivery Order contract worth $5,288.86 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BOSULIF 500 MG TABLET 30S. This contract has an ultimate completion date of November 4, 2024 and is a Firm Fixed Price agreement. AmerisourceBergen, through its Corporate Office Division, has been awarded this contract to provide essential pharmaceutical products to support military treatment...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $10,955.43 firm fixed-price contract is for the supply of BOSULIF 400 MG TABLET 30S, a pharmaceutical product. The award has an ultimate completion date of August 29, 2024 and is not a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of prescription...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $9,982.56 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for BOSULIF 100 MG TABLET 120S, a pharmaceutical product. The contract has a completion date of March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order, valued at $9,982.56, is for the supply of BOSULIF 100 MG TABLET 120S to support DLA Troop Support Medical programs. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceutical products and medical supplies to U.S. government agencies, particularly the Department of...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,288.86, is a delivery order for the supply of BOSULIF 500 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of December 5, 2024 and is a Firm Fixed Price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of BOSULIF 100 MG TABLET 120S, a pharmaceutical product. The contract has a ceiling value of $11,047.42 and an ultimate completion date of February 13, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,955.43, is for the delivery of BOSULIF 400 MG TABLET 30S, a specialty pharmaceutical product. The contract has an ultimate completion date of July 26, 2024 and uses a firm fixed price pricing structure. This delivery order is part of a larger Indefinite...
This federal contract award, with an ID of SPE2DB24D2010|SPE2DB25FZVS2, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,668.14, is for the delivery of BOSULIF 400 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of March 17, 2025. Amerisourcebergen Drug Corp, the prime contractor, does not...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $11,334.07, is a delivery order for the supply of the pharmaceutical product BOSULIF 400 MG TABLET 30S. The award has an ultimate completion date of March 24, 2025 and a firm fixed price pricing type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor...
This federal contract award, identified as SPE2DX15D1022|SPE2DX25FVCQS, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp. The contract, with a ceiling value of $22,668.14, is for the delivery of BOSULIF 400 MG TABLET 30S. This is a firm fixed-price delivery order contract with an ultimate completion date of March 18, 2025. The contract is not designated with any set-aside requirements, indicating open competition....
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJF72
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $10,678.36 to AmerisourceBergen Drug Corp's Corporate Office Division to provide 120-count tablets of the prescription medication Bosulif (100 mg). The contract has an ultimate completion date of August 6, 2024. AmerisourceBergen, a large pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by DLA and other federal agencies to supply a wide range of pharmaceutical and medical products, including critical care materials and specialty medications, to support military treatment facilities, veterans' hospitals, and other government healthcare programs nationwide. This particular delivery order does not have a set-aside designation.

Generated 10/15/24, 9:36 PM